Monday, February 3, 2025: Extraordinary General Meeting of Shareholders
Thursday, February 27, 2025: Analyst Briefing (the time proposed is indicative and the exact time will be announced promptly)
Thursday, February 27, 2025: Announcement of Proforma Consolidated Financial Results 2024
Monday, March 24,2025: Date of commencement for the trading of shares with a new nominal value